Andrew Ding
Graduate Student
Aging, Machine learning, Multi-scale interactions
Aging is the greatest risk factor for a broad range of chronic diseases. We have a long-standing interest in understanding the complex biology of aging from the level of the fundamental biological unit (the cell) to the level of the whole system (the organism). Such an understanding can be leveraged to discover and engineer interventions for broadly improving human health and staving off disease. To that end, we develop computational and machine learning tools to (1) measure biological aging from cell to organism, (2) predict and simulate the effects of interventions, including genetic and immune perturbations, on cells and tissues, and (3) design new interventions against aging and optimize their parameters for improved efficacy. We integrate computational frameworks for model building with experimental approaches for biological data generation and model validation.
Lab WebsiteEric obtained an A.B. in Chemistry and Physics and S.M. in Applied Mathematics from Harvard University in 2020. He completed his Ph.D. in Biomedical Informatics at Stanford University in 2025, where his research involved building computational methods for the analysis of spatial and single-cell omics and machine learning tools to track cellular and neuroimmune aging in the brain. Eric joined the Ragon Institute and MIT Biological Engineering in 2026.
Nature volume 638, pages 160–171 (2025)
Nature Methods volume 21, pages 444–454 (2024)
Nature Computational Science volume 3, pages 86–100 (2023)
Nature Aging volume 3, pages 121–137 (2023)
Graduate Student
Graduate Student